antibiotic g 418 has been researched along with puromycin in 12 studies
Studies (antibiotic g 418) | Trials (antibiotic g 418) | Recent Studies (post-2010) (antibiotic g 418) | Studies (puromycin) | Trials (puromycin) | Recent Studies (post-2010) (puromycin) |
---|---|---|---|---|---|
515 | 0 | 102 | 5,828 | 1 | 311 |
Protein | Taxonomy | antibiotic g 418 (IC50) | puromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.9 | |
Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 6.075 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 7 (58.33) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Kai, N; Kohmura, N; Mishina, M; Sanbo, M; Watanabe, S; Yagi, T; Yasuda, M | 1 |
Beverley, SM; Freedman, DJ | 1 |
Drews, RE; Kolker, MT; Moran, CP; Sachar, DS; Schnipper, LE | 1 |
Asada, M; Honda, E; Imamura, T | 1 |
Staffen, B; Theile, D; Weiss, J | 1 |
Akagi, K; Bradley, A; Horie, K; Huang, Y; Ikeda, R; Isotani, A; Kokubu, C; Oshitani, A; Takeda, J; Yoshida, J; Yusa, K | 1 |
Miura, H; Miyoshi, K; Ohtsuka, M; Sato, M; Watanabe, S | 1 |
Einarsson, E; Jerlström-Hultqvist, J; Svärd, SG | 1 |
Chi, Y; Gao, K; Li, G; Sun, W; Takeda, M; Yao, J; Zhang, H; Zhang, X | 1 |
Brodin, B; Helms, HC; Saaby, L | 1 |
Akamatsu, R; Horie, K; Ishida, Y; Kokubu, C; Kondo, R; Matsuba, A; Takeda, J; Tanaka, S; Tokunaga, M; Yamanishi, A | 1 |
Akbari, OS; Hay, BA; Hsu, AD; Kandul, NP; Liu, J | 1 |
12 other study(ies) available for antibiotic g 418 and puromycin
Article | Year |
---|---|
Stable production of mutant mice from double gene converted ES cells with puromycin and neomycin.
Topics: Acetyltransferases; Actins; Animals; Base Sequence; Cell Division; Chickens; Chimera; DNA Primers; Embryo, Mammalian; Embryo, Nonmammalian; Female; Genes, myc; Gentamicins; Humans; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Mice, Transgenic; Molecular Sequence Data; Neomycin; Polymerase Chain Reaction; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Proto-Oncogenes; Puromycin; Stem Cells | 1995 |
Two more independent selectable markers for stable transfection of Leishmania.
Topics: Animals; Base Sequence; DNA, Protozoan; Drug Resistance; Genes, Protozoan; Genetic Markers; Genetic Vectors; Gentamicins; Hygromycin B; Leishmania major; Molecular Sequence Data; Phleomycins; Puromycin; Transfection | 1993 |
Passage to nonselective media transiently alters growth of mycophenolic acid-resistant mammalian cells expressing the escherichia coli xanthine-guanine phosphoribosyltransferase gene: implications for sequential selection strategies.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Cell Division; Clone Cells; Drug Resistance; Escherichia coli; Gentamicins; Hygromycin B; Mice; Mycophenolic Acid; Pentosyltransferases; Protein Synthesis Inhibitors; Puromycin; Restriction Mapping; Transfection | 1996 |
Construction of pcDNA3.1-based vectors with blasticidin and puromycin resistance markers.
Topics: Animals; Biomarkers; CHO Cells; Cloning, Molecular; Cricetinae; DNA, Complementary; Genetic Vectors; Gentamicins; Nucleosides; Puromycin | 2006 |
ATP-binding cassette transporters as pitfalls in selection of transgenic cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Line, Transformed; Cinnamates; Dogs; Gentamicins; Humans; Hygromycin B; Puromycin; RNA, Messenger; Transfection; Transgenes | 2010 |
A homozygous mutant embryonic stem cell bank applicable for phenotype-driven genetic screening.
Topics: Animals; Biological Specimen Banks; Embryonic Stem Cells; Genomics; Gentamicins; Homozygote; Mice; Mutation; Phenotype; Polymorphism, Single Nucleotide; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proteins; Puromycin; RNA-Binding Proteins; Tissue Banks | 2011 |
Determination of the optimal concentration of several selective drugs useful for generating multi-transgenic porcine embryonic fibroblasts.
Topics: Acetyltransferases; Animals; Animals, Genetically Modified; Bleomycin; Cell Death; DNA; Drug Resistance; Female; Fibroblasts; Genetic Markers; Gentamicins; Gestational Age; Green Fluorescent Proteins; Hygromycin B; Nuclear Transfer Techniques; Nucleosides; Puromycin; Swine; Swine, Miniature; Transfection; Transgenes | 2012 |
Stable transfection of the diplomonad parasite Spironucleus salmonicida.
Topics: Acyltransferases; Aminohydrolases; Animals; Blotting, Western; Chromosomes; Cloning, Molecular; Diplomonadida; Escherichia coli; Genetic Markers; Genetic Vectors; Gentamicins; Glutathione Transferase; Hemagglutinins; Inhibitory Concentration 50; Kanamycin Kinase; Microscopy, Confocal; Nucleosides; Organisms, Genetically Modified; Plasmids; Porins; Promoter Regions, Genetic; Puromycin; Recombinant Proteins; Transfection | 2012 |
A novel TXNIP-based mechanism for Cx43-mediated regulation of oxidative drug injury.
Topics: Aminoglycosides; Animals; Carrier Proteins; Cell Cycle Proteins; Cell Death; Cell Line; Connexin 43; Doxorubicin; Gap Junctions; Gentamicins; Mice; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Puromycin; Rats; Signal Transduction | 2015 |
IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies.
Topics: Amebicides; Animals; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Caco-2 Cells; Cell Membrane Permeability; Drug Resistance, Multiple; Gentamicins; Humans; Immunoenzyme Techniques; Intestinal Mucosa; Puromycin; Substrate Specificity; Swine | 2016 |
Collection of homozygous mutant mouse embryonic stem cells arising from autodiploidization during haploid gene trap mutagenesis.
Topics: Animals; Cells, Cultured; Diploidy; DNA Transposable Elements; Flow Cytometry; Genetic Vectors; Gentamicins; Haploidy; Homozygote; Mice; Mouse Embryonic Stem Cells; Mutagenesis; Poly A; Puromycin; Reproducibility of Results | 2018 |
A drug-inducible sex-separation technique for insects.
Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Drug Resistance; Exons; Female; Genetic Engineering; Genetics, Population; Gentamicins; Homozygote; Introns; Male; Pest Control; Puromycin; RNA Splicing; Sex Determination Analysis | 2020 |